China SXT Pharmaceuticals
SXTC
SXTC
6 hedge funds and large institutions have $65.5K invested in China SXT Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53% less capital invested
Capital invested by funds: $139K → $65.5K (-$73.4K)
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$15.8K | |
| 2 | +$10K | |
| 3 | +$7.02K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.1K |